The Clorox Company (NYSE:CLX) Shares Sold by Worldquant Millennium Advisors LLC

Worldquant Millennium Advisors LLC decreased its holdings in The Clorox Company (NYSE:CLX - Free Report) by 42.0% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 31,044 shares of the company's stock after selling 22,463 shares during the quarter. Worldquant Millennium Advisors LLC's holdings in Clorox were worth $5,057,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently bought and sold shares of CLX. Insight Folios Inc increased its holdings in shares of Clorox by 3.0% in the 3rd quarter. Insight Folios Inc now owns 2,195 shares of the company's stock valued at $358,000 after purchasing an additional 63 shares in the last quarter. Fiduciary Group LLC increased its holdings in Clorox by 0.4% in the second quarter. Fiduciary Group LLC now owns 19,050 shares of the company's stock valued at $2,600,000 after buying an additional 72 shares in the last quarter. GHP Investment Advisors Inc. increased its holdings in Clorox by 2.0% in the second quarter. GHP Investment Advisors Inc. now owns 3,634 shares of the company's stock valued at $496,000 after buying an additional 72 shares in the last quarter. SPC Financial Inc. lifted its position in shares of Clorox by 2.2% during the 2nd quarter. SPC Financial Inc. now owns 3,485 shares of the company's stock valued at $476,000 after acquiring an additional 75 shares during the period. Finally, Massmutual Trust Co. FSB ADV boosted its stake in shares of Clorox by 17.2% during the 3rd quarter. Massmutual Trust Co. FSB ADV now owns 510 shares of the company's stock worth $83,000 after acquiring an additional 75 shares in the last quarter. Institutional investors and hedge funds own 78.53% of the company's stock.

Analyst Ratings Changes

Several equities analysts recently weighed in on the company. Evercore ISI dropped their price objective on Clorox from $140.00 to $139.00 and set an "underperform" rating for the company in a research note on Monday, October 14th. BNP Paribas raised Clorox to a "strong sell" rating in a research note on Friday, September 6th. Jefferies Financial Group raised shares of Clorox from a "hold" rating to a "buy" rating and increased their price objective for the company from $174.00 to $187.00 in a research note on Tuesday, October 1st. Citigroup lifted their target price on shares of Clorox from $165.00 to $170.00 and gave the stock a "neutral" rating in a research report on Friday, September 6th. Finally, DA Davidson increased their price target on shares of Clorox from $153.00 to $171.00 and gave the company a "neutral" rating in a research report on Monday, November 4th. Five analysts have rated the stock with a sell rating, nine have assigned a hold rating and one has assigned a buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of "Hold" and a consensus price target of $155.00.

Clorox Trading Down 1.6 %

Shares of CLX stock traded down $2.77 during mid-day trading on Friday, hitting $166.97. 1,217,064 shares of the company's stock were exchanged, compared to its average volume of 1,054,507. The stock has a market cap of $20.67 billion, a price-to-earnings ratio of 58.18, a PEG ratio of 3.10 and a beta of 0.42. The stock has a 50-day simple moving average of $163.50 and a two-hundred day simple moving average of $150.49. The Clorox Company has a fifty-two week low of $127.60 and a fifty-two week high of $171.37. The company has a quick ratio of 0.62, a current ratio of 1.00 and a debt-to-equity ratio of 11.08.

Clorox (NYSE:CLX - Get Free Report) last issued its quarterly earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.36 by $0.50. The firm had revenue of $1.76 billion for the quarter, compared to analyst estimates of $1.64 billion. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The firm's quarterly revenue was up 27.0% on a year-over-year basis. During the same period last year, the company earned $0.49 EPS. Equities analysts expect that The Clorox Company will post 6.85 EPS for the current fiscal year.

Clorox Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Wednesday, January 29th will be paid a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a yield of 2.92%. The ex-dividend date is Wednesday, January 29th. Clorox's dividend payout ratio is currently 170.03%.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.